HIF1A and neoplasm: Similarly, BCRT1 is an M2 polarizing lncRNA that is upregulated in response to tumor hypoxia and leads to breast cancer progression via novel HIF-1α/lncRNA BCRT1/miR-1303/PTBP3 pathway (93).